137 related articles for article (PubMed ID: 19439326)
21. Natural products of relevance in the prevention and supportive treatment of depression.
Muszyńska B; Łojewski M; Rojowski J; Opoka W; Sułkowska-Ziaja K
Psychiatr Pol; 2015; 49(3):435-53. PubMed ID: 26276913
[TBL] [Abstract][Full Text] [Related]
22. Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.
Cunha MP; Pazini FL; Rosa JM; Ramos-Hryb AB; Oliveira Á; Kaster MP; Rodrigues AL
Purinergic Signal; 2015 Jun; 11(2):215-27. PubMed ID: 25702084
[TBL] [Abstract][Full Text] [Related]
23. Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain.
Shinomol GK; Muralidhara
Phytomedicine; 2011 Feb; 18(4):317-26. PubMed ID: 20850955
[TBL] [Abstract][Full Text] [Related]
24. Improvement of memory recall by quercetin in rodent contextual fear conditioning and human early-stage Alzheimer's disease patients.
Nakagawa T; Itoh M; Ohta K; Hayashi Y; Hayakawa M; Yamada Y; Akanabe H; Chikaishi T; Nakagawa K; Itoh Y; Muro T; Yanagida D; Nakabayashi R; Mori T; Saito K; Ohzawa K; Suzuki C; Li S; Ueda M; Wang MX; Nishida E; Islam S; Tana ; Kobori M; Inuzuka T
Neuroreport; 2016 Jun; 27(9):671-6. PubMed ID: 27145228
[TBL] [Abstract][Full Text] [Related]
25. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
[TBL] [Abstract][Full Text] [Related]
26. Nicotinic receptors and attention.
Hahn B
Curr Top Behav Neurosci; 2015; 23():103-35. PubMed ID: 25655889
[TBL] [Abstract][Full Text] [Related]
27. An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children.
Dave UP; Dingankar SR; Saxena VS; Joseph JA; Bethapudi B; Agarwal A; Kudiganti V
Adv Mind Body Med; 2014; 28(2):10-5. PubMed ID: 24682000
[TBL] [Abstract][Full Text] [Related]
28. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood.
Benson S; Downey LA; Stough C; Wetherell M; Zangara A; Scholey A
Phytother Res; 2014 Apr; 28(4):551-9. PubMed ID: 23788517
[TBL] [Abstract][Full Text] [Related]
29. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.
Sathyanarayanan V; Thomas T; Einöther SJ; Dobriyal R; Joshi MK; Krishnamachari S
Psychopharmacology (Berl); 2013 May; 227(2):299-306. PubMed ID: 23354535
[TBL] [Abstract][Full Text] [Related]
30. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
Downey LA; Kean J; Nemeh F; Lau A; Poll A; Gregory R; Murray M; Rourke J; Patak B; Pase MP; Zangara A; Lomas J; Scholey A; Stough C
Phytother Res; 2013 Sep; 27(9):1407-13. PubMed ID: 23281132
[TBL] [Abstract][Full Text] [Related]
31. Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A.
Mathew J; Balakrishnan S; Antony S; Abraham PM; Paulose CS
J Biomed Sci; 2012 Feb; 19(1):25. PubMed ID: 22364254
[TBL] [Abstract][Full Text] [Related]
32. Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain.
Shinomol GK; Mythri RB; Srinivas Bharath MM; Muralidhara
Cell Mol Neurobiol; 2012 Apr; 32(3):455-65. PubMed ID: 22160863
[TBL] [Abstract][Full Text] [Related]
33. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster.
Hosamani R; Muralidhara
Neurotoxicology; 2009 Nov; 30(6):977-85. PubMed ID: 19744517
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of Bacopa monniera whole-plant extract against aluminum-induced hippocampus damage in rats: evidence from electron microscopic images.
Nannepaga JS; Korivi M; Tirumanyam M; Bommavaram M; Kuo CH
Chin J Physiol; 2014 Oct; 57(5):279-85. PubMed ID: 25241988
[TBL] [Abstract][Full Text] [Related]
36. Ethanolic extracts of Alstonia Scholaris and Bacopa Monniera possess neuroleptic activity due to anti-dopaminergic effect.
Jash R; Chowdary KA
Pharmacognosy Res; 2014 Jan; 6(1):46-51. PubMed ID: 24497742
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic potential of agomelatine in epilepsy and epileptic complications.
Vimala PV; Bhutada PS; Patel FR
Med Hypotheses; 2014 Jan; 82(1):105-10. PubMed ID: 24314750
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats.
Thomas RB; Joy S; Ajayan MS; Paulose CS
Cell Mol Neurobiol; 2013 Nov; 33(8):1065-74. PubMed ID: 23975094
[TBL] [Abstract][Full Text] [Related]
39. Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonism.
Ring RM; Regan CM
J Psychopharmacol; 2013 Oct; 27(10):930-9. PubMed ID: 23863923
[TBL] [Abstract][Full Text] [Related]
40. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C
J Altern Complement Med; 2012 Jul; 18(7):647-52. PubMed ID: 22747190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
